Tycel Jovelle Phillips (Tycel Phillips, Tycel J Phillips)

ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 38

Top Venues

American journal of hematology

Blood advances

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Blood

This page only lists publications with an associated author ORCID identifier.

Publications

Sam Yuen, Tycel Jovelle Phillips, Rajat Bannerji, Paula Marlton, Giuseppe Gritti, John F Seymour, Anna Johnston, Christopher Arthur, Anna Dodero, Sunil Sharma, Jamie Hirata, Lisa Musick, Christopher R Flowers
Polatuzumab vedotin, venetoclax, and an anti-CD20 monoclonal antibody in relapsed/refractory B-cell non-Hodgkin lymphoma. American journal of hematology (2024)
Michael L Wang, Tadeusz Robak, Kami J Maddocks, Tycel Jovelle Phillips, Stephen Douglas Smith, David Gallinson, Roser Calvo, Chuan-Chuan Wun, Veerendra Munugalavadla, Wojciech Jurczak
Acalabrutinib plus venetoclax and rituximab in treatment-naive mantle cell lymphoma: 2-year safety and efficacy analysis. Blood advances (2024)
Jennifer L Crombie, Tara Graff, Lorenzo Falchi, Yasmin H Karimi, Rajat Bannerji, Loretta J Nastoupil, Catherine Thieblemont, Renata Ursu, Nancy L Bartlett, Victoria R Nachar, Jonathan Weiss, Jane Osterson, Krish Patel, Joshua D Brody, Jeremy S Abramson, Matthew A Lunning, Nirav N Shah, Ayed Ayed, Manali Kamdar, Benjamin M Parsons, Paolo Caimi, Ian W Flinn, Alex F Herrera, Jeff P Sharman, Marshall McKenna, Philippe Armand, Brad S Kahl, Sonali M Smith, Andrew D Zelenetz, L Elizabeth Elizabeth Budde, Martin Hutchings, Tycel Jovelle Phillips, Michael J Dickinson
Consensus Recommendations on the Management of Toxicity Associated with CD3xCD20 Bispecific Antibody Therapy. Blood (2024)
Michael L Wang, Tadeusz Robak, Kami J Maddocks, Tycel Jovelle Phillips, Stephen D Smith, David Gallinson, Roser Calvo, Chuan-Chuan Wun, Veerendra Munugalavadla, Wojciech Jurczak
Acalabrutinib plus venetoclax and rituximab in treatment-naive mantle cell lymphoma: 2-year safety and efficacy analysis. Blood advances 8 (17) (2024)
Jonathan M Weiss, Tycel Jovelle Phillips
Taking a BiTE out of Lymphoma: Bispecific Antibodies in B-Cell Non-Hodgkin Lymphoma. Cancers 16 (9) (2024)
Sam Yuen, Tycel Jovelle Phillips, Rajat Bannerji, Paula Marlton, Giuseppe Gritti, John F Seymour, Anna Johnston, Christopher Arthur, Anna Dodero, Sunil Sharma, Jamie Hirata, Lisa Musick, Christopher R Flowers
Polatuzumab vedotin, venetoclax, and an anti-CD20 monoclonal antibody in relapsed/refractory B-cell non-Hodgkin lymphoma. American journal of hematology 99 (7) (2024)
Michael L Wang, Tadeusz Robak, Kami J Maddocks, Tycel Jovelle Phillips, Stephen D Smith, David Gallinson, Roser Calvo, Chuan-Chuan Wun, Veerendra Munugalavadla, Wojciech Jurczak
Acalabrutinib plus venetoclax and rituximab in treatment-naive mantle cell lymphoma: 2-year safety and efficacy analysis. Blood advances 8 (17) (2024)
Jonathan M Weiss, Tycel Jovelle Phillips
Taking a BiTE out of Lymphoma: Bispecific Antibodies in B-Cell Non-Hodgkin Lymphoma. Cancers 16 (9) (2024)
Sam Yuen, Tycel Jovelle Phillips, Rajat Bannerji, Paula Marlton, Giuseppe Gritti, John F Seymour, Anna Johnston, Christopher Arthur, Anna Dodero, Sunil Sharma, Jamie Hirata, Lisa Musick, Christopher R Flowers
Polatuzumab vedotin, venetoclax, and an anti-CD20 monoclonal antibody in relapsed/refractory B-cell non-Hodgkin lymphoma. American journal of hematology 99 (7) (2024)
Jennifer L Crombie, Tara Graff, Lorenzo Falchi, Yasmin H Karimi, Rajat Bannerji, Loretta J Nastoupil, Catherine Thieblemont, Renata Ursu, Nancy L Bartlett, Victoria Nachar, Jonathan Weiss, Jane Osterson, Krish Patel, Joshua D Brody, Jeremy S Abramson, Matthew A Lunning, Nirav N Shah, Ayed Ayed, Manali Kamdar, Benjamin Parsons, Paolo F Caimi, Ian W Flinn, Alex F Herrera, Jeffrey Sharman, Marshall McKenna, Philippe Armand, Brad S Kahl, Sonali M Smith, Andrew D Zelenetz, L Elizabeth Elizabeth Budde, Martin Hutchings, Tycel Jovelle Phillips, Michael J Dickinson
Consensus recommendations on the management of toxicity associated with CD3×CD20 bispecific antibody therapy. Blood 143 (16) (2024)
Sam Yuen, Tycel Jovelle Phillips, Rajat Bannerji, Paula Marlton, Giuseppe Gritti, John F Seymour, Anna Johnston, Christopher Arthur, Anna Dodero, Sunil Sharma, Jamie Hirata, Lisa Musick, Christopher R Flowers
Polatuzumab vedotin, venetoclax, and an anti-CD20 monoclonal antibody in relapsed/refractory B-cell non-Hodgkin lymphoma. American journal of hematology 99 (7) (2024)
Tycel Jovelle Phillips, Abraham Avigdor, Ronit Gurion, Caterina Patti, Paolo Corradini, Monica Tani, Amitkumar Mehta, Izidore S Lossos, Pier Luigi Luigi Zinzani, Catherine Thieblemont, Wojciech Jurczak, Fred Zheng, Erica Rappold, Wanying Zhao, Ping Jiang, Peter W M Johnson
A phase 2 study of the PI3Kδ inhibitor parsaclisib in relapsed and refractory marginal zone lymphoma (CITADEL-204). Blood advances 8 (4) (2024)
Jennifer L Crombie, Tara Graff, Lorenzo Falchi, Yasmin H Karimi, Rajat Bannerji, Loretta J Nastoupil, Catherine Thieblemont, Renata Ursu, Nancy L Bartlett, Victoria R Nachar, Jonathan Weiss, Jane Osterson, Krish Patel, Joshua D Brody, Jeremy S Abramson, Matthew A Lunning, Nirav N Shah, Ayed Ayed, Manali Kamdar, Benjamin M Parsons, Paolo Caimi, Ian W Flinn, Alex F Herrera, Jeff P Sharman, Marshall McKenna, Philippe Armand, Brad S Kahl, Sonali M Smith, Andrew D Zelenetz, L Elizabeth Elizabeth Budde, Martin Hutchings, Tycel Jovelle Phillips, Michael J Dickinson
Consensus Recommendations on the Management of Toxicity Associated with CD3xCD20 Bispecific Antibody Therapy. Blood (2024)
Tycel Jovelle Phillips, Abraham Avigdor, Ronit Gurion, Caterina Patti, Paolo Corradini, Monica Tani, Amitkumar Mehta, Izidore S Lossos, Pier Luigi Luigi Zinzani, Catherine Thieblemont, Wojciech Jurczak, Fred Zheng, Erica Rappold, Wanying Zhao, Ping Jiang, Peter W M Johnson
A phase 2 study of the PI3Kδ inhibitor parsaclisib in relapsed and refractory marginal zone lymphoma (CITADEL-204). Blood advances 8 (4) (2024)
Elisabeth A Lasater, Dhara N Amin, Rajat Bannerji, Raghuveer Singh Mali, Kathy Barrett, Ryan N Rys, Jason Oeh, Eva Lin, Tim Sterne-Weiler, Ellen Rei Ingalla, MaryAnn Go, Shang-Fan Yu, Maxwell M Krem, Chris Arthur, Uwe Hahn, Anna Johnston, Vinit Karur, Nadia Khan, Paula Marlton, Tycel Jovelle Phillips, Giuseppe Gritti, John F Seymour, Monica Tani, Sam Yuen, Scott Martin, Matthew T Chang, Christopher M Rose, Victoria C Pham, Andrew G Polson, YiMeng Chang, Claudia Wever, Nathalie A Johnson, Yanwen Jiang, Jamie Hirata, Deepak Sampath, Lisa Musick, Christopher R Flowers, Ingrid E Wertz
Targeting MCL-1 and BCL-2 with polatuzumab vedotin and venetoclax overcomes treatment resistance in R/R non-Hodgkin lymphoma: Results from preclinical models and a Phase Ib study. American journal of hematology 98 (3) (2023)
Tycel Jovelle Phillips, Abraham Avigdor, Ronit Gurion, Caterina Patti, Paolo Corradini, Monica Tani, Amitkumar Mehta, Izidore S Lossos, Pier Luigi Luigi Zinzani, Catherine Thieblemont, Wojciech Jurczak, Fred Zheng, Erica Rappold, Wanying Zhao, Ping Jiang, Peter W M Johnson
A phase 2 study of the PI3Kδ inhibitor parsaclisib in relapsed and refractory marginal zone lymphoma (CITADEL-204). Blood advances (2023)
Vi Lam, Carly Roleder, Tingting Liu, Nur Bruss, Scott Best, Xiaoguang Wang, Tycel Jovelle Phillips, Geoffrey Shouse, Allison J Berger, Lapo Alinari, Lili Wang, Tanya Siddiqi, Nathan D Pennock, Alexey V Danilov
T cell-intrinsic immunomodulatory effects of TAK-981 (subasumstat), a SUMO-activating enzyme inhibitor, in chronic lymphocytic leukemia. Molecular cancer therapeutics (2023)
Tycel Jovelle Phillips, David A Bond, Radhika Takiar, Karson J Kump, Malathi Kandarpa, Philip Boonstra, Tera Lynn Mayer, Victoria R Nachar, Ryan A Wilcox, Shannon Ann Carty, Yasmin H Karimi, Zaneta Nikolovska-Coleska, Mark S Kaminski, Alex F Herrera, Kami Maddocks, Leslie L Popplewell, Alexey V Danilov
Adding venetoclax to lenalidomide and rituximab is safe and effective in patients with untreated mantle cell lymphoma. Blood advances (2023)
Radhika Takiar, Tycel Jovelle Phillips
Durable Responses with ALK Inhibitors for Primary Refractory Anaplastic Lymphoma Kinase-Positive Large B Cell Lymphoma. Blood advances (2023)
Kang Le, Jing Sun, Javid Ghaemmaghami, Mitchell R Smith, W K Eddie Ip, Tycel Jovelle Phillips, Mamta Gupta
Blockade of CCR1 induces a phenotypic shift in macrophages and triggers a favorable antilymphoma activity. Blood advances (2023)
John M Burke, Nicholas Liu, Kristina S Yu, Michelle A Fanale, Andy Surinach, Carlos Flores Avile, Julie Lisano, Tycel Jovelle Phillips
Retrospective Analysis With Propensity Score Matching of Peripheral T-Cell Lymphoma Treated Frontline With Brentuximab Vedotin and Chemotherapy. The oncologist (2023)
Elisabeth A Lasater, Dhara N Amin, Rajat Bannerji, Raghuveer Singh Mali, Kathy Barrett, Ryan N Rys, Jason Oeh, Eva Lin, Tim Sterne-Weiler, Ellen Rei Ingalla, MaryAnn Go, Shang-Fan Yu, Maxwell M Krem, Chris Arthur, Uwe Hahn, Anna Johnston, Vinit Karur, Nadia Khan, Paula Marlton, Tycel Jovelle Phillips, Giuseppe Gritti, John F Seymour, Monica Tani, Sam Yuen, Scott Martin, Matthew T Chang, Christopher M Rose, Victoria C Pham, Andrew G Polson, YiMeng Chang, Claudia Wever, Nathalie A Johnson, Yanwen Jiang, Jamie Hirata, Deepak Sampath, Lisa Musick, Christopher R Flowers, Ingrid E Wertz
Targeting MCL-1 and BCL-2 with polatuzumab vedotin and venetoclax overcomes treatment resistance in R/R non-Hodgkin lymphoma: Results from preclinical models and a Phase Ib study. American journal of hematology (2023)
Adam J Olszewski, Tycel Jovelle Phillips, Marc S Hoffmann, Philippe Armand, Tae Min Kim, Dok Hyun Yoon, Amitkumar Mehta, Richard Greil, Jason R Westin, Izidore S Lossos, Javier L Muñoz, Jason Sit, Michael C Wei, Annie Yang, Vivian Chen, Enkhtsetseg Purev, Donald L Yee, Ulrich Jäger
Mosunetuzumab in combination with CHOP in previously untreated DLBCL: safety and efficacy results from a phase 2 study. Blood advances (2023)
Elisabeth A Lasater, Dhara N Amin, Rajat Bannerji, Raghuveer Singh Mali, Kathy Barrett, Ryan N Rys, Jason Oeh, Eva Lin, Tim Sterne-Weiler, Ellen Rei Ingalla, MaryAnn Go, Shang-Fan Yu, Maxwell M Krem, Chris Arthur, Uwe Hahn, Anna Johnston, Vinit Karur, Nadia Khan, Paula Marlton, Tycel Jovelle Phillips, Giuseppe Gritti, John F Seymour, Monica Tani, Sam Yuen, Scott Martin, Matthew T Chang, Christopher M Rose, Victoria C Pham, Andrew G Polson, YiMeng Chang, Claudia Wever, Nathalie A Johnson, Yanwen Jiang, Jamie Hirata, Deepak Sampath, Lisa Musick, Christopher R Flowers, Ingrid E Wertz
Targeting MCL-1 and BCL-2 with polatuzumab vedotin and venetoclax overcomes treatment resistance in R/R non-Hodgkin lymphoma: Results from preclinical models and a Phase Ib study. American journal of hematology 98 (3) (2023)
Elisabeth A Lasater, Dhara N Amin, Rajat Bannerji, Raghuveer Singh Mali, Kathy Barrett, Ryan N Rys, Jason Oeh, Eva Lin, Tim Sterne-Weiler, Ellen Rei Ingalla, MaryAnn Go, Shang-Fan Yu, Maxwell M Krem, Chris Arthur, Uwe Hahn, Anna Johnston, Vinit Karur, Nadia Khan, Paula Marlton, Tycel Jovelle Phillips, Giuseppe Gritti, John F Seymour, Monica Tani, Sam Yuen, Scott Martin, Matthew T Chang, Christopher M Rose, Victoria C Pham, Andrew G Polson, YiMeng Chang, Claudia Wever, Nathalie A Johnson, Yanwen Jiang, Jamie Hirata, Deepak Sampath, Lisa Musick, Christopher R Flowers, Ingrid E Wertz
Targeting MCL-1 and BCL-2 with polatuzumab vedotin and venetoclax overcomes treatment resistance in R/R non-Hodgkin lymphoma: Results from preclinical models and a Phase Ib study. American journal of hematology 98 (3) (2023)
Elisabeth A Lasater, Dhara N Amin, Rajat Bannerji, Raghuveer Singh Mali, Kathy Barrett, Ryan N Rys, Jason Oeh, Eva Lin, Tim Sterne-Weiler, Ellen Rei Ingalla, MaryAnn Go, Shang-Fan Yu, Maxwell M Krem, Chris Arthur, Uwe Hahn, Anna Johnston, Vinit Karur, Nadia Khan, Paula Marlton, Tycel Jovelle Phillips, Giuseppe Gritti, John F Seymour, Monica Tani, Sam Yuen, Scott Martin, Matthew T Chang, Christopher M Rose, Victoria C Pham, Andrew G Polson, YiMeng Chang, Claudia Wever, Nathalie A Johnson, Jiang Yanwen, Jamie Hirata, Deepak Sampath, Lisa Musick, Christopher R Flowers, Ingrid E Wertz
Targeting MCL-1 and BCL-2 with polatuzumab vedotin and venetoclax overcomes treatment resistance in R/R NHL: Results from preclinical models and a Phase Ib study. American journal of hematology (2023)
Elisabeth A Lasater, Dhara N Amin, Rajat Bannerji, Raghuveer Singh Mali, Kathy Barrett, Ryan N Rys, Jason Oeh, Eva Lin, Tim Sterne-Weiler, Ellen Rei Ingalla, MaryAnn Go, Shang-Fan Yu, Maxwell M Krem, Chris Arthur, Uwe Hahn, Anna Johnston, Vinit Karur, Nadia Khan, Paula Marlton, Tycel Jovelle Phillips, Giuseppe Gritti, John F Seymour, Monica Tani, Sam Yuen, Scott Martin, Matthew T Chang, Christopher M Rose, Victoria C Pham, Andrew G Polson, YiMeng Chang, Claudia Wever, Nathalie A Johnson, Yanwen Jiang, Jamie Hirata, Deepak Sampath, Lisa Musick, Christopher R Flowers, Ingrid E Wertz
Targeting MCL-1 and BCL-2 with polatuzumab vedotin and venetoclax overcomes treatment resistance in R/R non-Hodgkin lymphoma: Results from preclinical models and a Phase Ib study. American journal of hematology 98 (3) (2023)
Catherine Thieblemont, Tycel Jovelle Phillips, Hervé Ghesquières, Chan Yoon Y Cheah, Michael Roost Clausen, David Cunningham, Young Rok Do, Tatyana Feldman, Robin Gasiorowski, Wojciech Jurczak, Tae Min Kim, David John Lewis, Marjolein van der Poel, Michelle Limei Poon, Mariana Cota Stirner, Nurgul Kilavuz, Christopher Chiu, Menghui Chen, Mariana Sacchi, Brian Elliott, Tahamtan Ahmadi, Martin Hutchings, Pieternella J Lugtenburg
Epcoritamab, a Novel, Subcutaneous CD3xCD20 Bispecific T-Cell-Engaging Antibody, in Relapsed or Refractory Large B-Cell Lymphoma: Dose Expansion in a Phase I/II Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2022)
Catherine Thieblemont, Tycel Jovelle Phillips, Hervé Ghesquières, Chan Yoon Y Cheah, Michael Roost Clausen, David Cunningham, Young Rok Do, Tatyana Feldman, Robin Gasiorowski, Wojciech Jurczak, Tae Min Kim, David John Lewis, Marjolein van der Poel, Michelle Limei Poon, Mariana Cota Stirner, Nurgul Kilavuz, Christopher Chiu, Menghui Chen, Mariana Sacchi, Brian Elliott, Tahamtan Ahmadi, Martin Hutchings, Pieternella J Lugtenburg
Epcoritamab, a Novel, Subcutaneous CD3xCD20 Bispecific T-Cell-Engaging Antibody, in Relapsed or Refractory Large B-Cell Lymphoma: Dose Expansion in a Phase I/II Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2022)
Tycel Jovelle Phillips, Mark Brunvand, Andy I Chen, James Essell, Annalisa Chiappella, Catherine Diefenbach, Ji Cheng, David Ramies, Jamie Hirata, Franck Morschhauser, Ian W Flinn
Safety and efficacy of polatuzumab vedotin + obinutuzumab for relapsed/refractory non-Hodgkin lymphomas: A phase IB/II study. American journal of hematology (2021)
Radhika Takiar, Tycel Jovelle Phillips
Non-chemotherapy Options for Newly Diagnosed Mantle Cell Lymphoma. Current treatment options in oncology 22 (11) (2021)
Nathan H Fowler, Felipe Samaniego, Wojciech Jurczak, Nilanjan Ghosh, Enrico Derenzini, James A Reeves, Wanda Knopińska-Posłuszny, Chan Yoon Y Cheah, Tycel Jovelle Phillips, Ewa Lech-Maranda, Bruce D Cheson, Paolo F Caimi, Sebastian Grosicki, Lori A Leslie, Julio C Chavez, Gustavo Fonseca, Sunil Babu, Daniel James Hodson, Spencer H Shao, John M Burke, Jeff P Sharman, Jennie Y Law, John M Pagel, Hari P Miskin, Peter Sportelli, Owen A O'Connor, Michael S Weiss, Pier Luigi Luigi Zinzani
Umbralisib, a Dual PI3Kδ/CK1ε Inhibitor in Patients With Relapsed or Refractory Indolent Lymphoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (15) (2021)
Adam J Olszewski, Lasse Hjort Kyneb Jakobsen, Graham P Collins, Kate Cwynarski, Veronika Bachanova, Kristie A Blum, Kirsten M Boughan, Mark Bower, Alessia Dalla Pria, Alexey Danilov, Kevin A David, Catherine S Diefenbach, Fredrik Ellin, Narendranath Epperla, Umar Farooq, Tatyana A Feldman, Alina S Gerrie, Deepa Jagadeesh, Manali Kamdar, Reem Karmali, Shireen Kassam, Vaishalee P Kenkre, Nadia Khan, Seo-Hyun Kim, Andreas K Klein, Izidore S Lossos, Matthew A Lunning, Peter Martin, Nicolás Martinez-Calle, Silvia Montoto, Seema Naik, Neil Palmisiano, David J Peace, Elizabeth H Phillips, Tycel Jovelle Phillips, Craig A Portell, Nishitha M Reddy, Anna Santarsieri, Maryam Sarraf Yazdy, Knut B Smeland, Scott E Smith, Stephen Douglas Smith, Suchitra Sundaram, Adam Stephen Zayac, Xiao-Yin Zhang, Catherine Zhu, Chan Yoon Y Cheah, Tarec C El-Galaly, Andrew M Evens
Burkitt Lymphoma International Prognostic Index. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (10) (2021)
Jennifer Girard, Yasmin Karimi, Shannon Carty, Ryan Wilcox, Mark Kaminiski, Sami Malek, Tycel Jovelle Phillips
Targeted Therapies for Follicular Lymphoma. Current hematologic malignancy reports 16 (1) (2021)
Philippe Armand, Niels Murawski, Daniel Molin, Jasmine Zain, Barbara Eichhorst, Zafer Gulbas, Eliza A Hawkes, John M Pagel, Tycel Jovelle Phillips, Vincent Ribrag, Jakub Svoboda, Anastasios Stathis, Arkendu Chatterjee, Robert Orlowski, Patricia Marinello, Beth Christian
Pembrolizumab in relapsed or refractory Richter syndrome. British journal of haematology 190 (2) (2020)
Marcus Geer, Emily K Roberts, Maryann Shango, Brian G Till, Stephen D Smith, Hashim Abbas, Brian T Hill, Jason Kaplan, Paul M Barr, Paolo Caimi, Deborah M Stephens, Emily Lin, Alex F Herrera, Evan Rosenbaum, Jennifer E Amengual, Philip S Boonstra, Sumana Devata, Ryan A Wilcox, Mark S Kaminski, Tycel Jovelle Phillips
Multicentre retrospective study of intravascular large B-cell lymphoma treated at academic institutions within the United States. British journal of haematology 186 (2) (2019)
Jennifer Girard, John Reneau, Sumana Devata, Ryan A Wilcox, Mark S Kaminski, Jessica Mercer, Shannon Carty, Tycel Jovelle Phillips
Evaluating Acalabrutinib In The Treatment Of Mantle Cell Lymphoma: Design, Development, And Place In Therapy. OncoTargets and therapy 12 (2019)
Tycel Jovelle Phillips, Paul M Barr, Steven I Park, Kathryn Kolibaba, Paolo F Caimi, Saurabh Chhabra, Edwin C Kingsley, Thomas Boyd, Robert Chen, Anne-Sophie Carret, Elaina M Gartner, Hong Li, Cindy Yu, David C Smith
A phase 1 trial of SGN-CD70A in patients with CD70-positive diffuse large B cell lymphoma and mantle cell lymphoma. Investigational new drugs 37 (2) (2018)

Tycel Jovelle Phillips.css-eqlu8i{font-size:small;padding-left:4px;} (Tycel Phillips, Tycel J Phillips)

Publication Activity (10 Years)

Top Topics

Top Venues

Tycel Jovelle Phillips (Tycel Phillips, Tycel J Phillips)